Literature DB >> 9157866

Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma.

H Irie1, H Honda, K Kaneko, T Kuroiwa, K Yoshimitsu, K Masuda.   

Abstract

BACKGROUND: To compare the value of helical computed tomography (CT) and various pulse sequences of magnetic resonance (MR) imaging in the detection and staging of small pancreatic adenocarcinoma.
METHODS: Small pancreatic adenocarcinomas (< or = 2 cm in diameter) in eight patients were evaluated with both helical CT and MR imaging. Five MR imaging pulse sequences that included fat-suppressed T1-weighted images and dynamic study using fast multiplanar spoiled gradient-recalled technique were compared for the tumor detectability. To evaluate the tumor vascularity, angiographic findings were also investigated.
RESULTS: Helical CT delineated the tumor in five cases, and MR imaging depicted the tumor in seven cases. MR imaging could detect the tumor of 0.8 cm in diameter clearly. Although helical CT and dynamic MR imaging missed the tumor of 2 cm with relative hypervascularity, fat-suppressed T1-weighted MR imaging demonstrated it precisely. As for the tumor staging, MR imaging was equal or slightly superior to helical CT.
CONCLUSION: MR imaging is the first modality of choice to evaluate small pancreatic adenocarcinoma, and fat-suppressed T1-weighted images and dynamic study must be performed.

Entities:  

Mesh:

Year:  1997        PMID: 9157866     DOI: 10.1007/s002619900226

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  20 in total

Review 1.  Multidetector CT and three-dimensional imaging of the pancreas: state of the art.

Authors:  Karen M Horton
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

Review 2.  Magnetic resonance imaging of the pancreas in 2001.

Authors:  Caroline Reinhold
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

Review 3.  Magnetic resonance imaging of pancreatic adenocarcinoma.

Authors:  L M Fayad; D G Mitchell
Journal:  Int J Gastrointest Cancer       Date:  2001

4.  Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma.

Authors:  Dustin M Walters; Damien J Lapar; Eduard E de Lange; Marc Sarti; Jayme B Stokes; Reid B Adams; Todd W Bauer
Journal:  Ann Surg Oncol       Date:  2011-04-12       Impact factor: 5.344

Review 5.  Pancreatic adenocarcinoma.

Authors:  Wolfgang Schima; Ahmed Ba-Ssalamah; Claus Kölblinger; Christiane Kulinna-Cosentini; Andreas Puespoek; Peter Götzinger
Journal:  Eur Radiol       Date:  2006-10-05       Impact factor: 5.315

Review 6.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

7.  Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Nigel Balfour Jamieson; Alan K Foulis; Karin A Oien; Euan J Dickson; Clem W Imrie; Ross Carter; Colin J McKay
Journal:  J Gastrointest Surg       Date:  2010-11-30       Impact factor: 3.452

8.  Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI.

Authors:  Ling-Fei Wu; Bing-Zhou Wang; Jia-Lin Feng; Wei-Rong Cheng; Guo-Re Liu; Xiao-Hua Xu; Zhi-Chao Zheng
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Does Second Reader Opinion Affect Patient Management in Pancreatic Ductal Adenocarcinoma?

Authors:  Giuseppe Corrias; Sandra Huicochea Castellanos; Ryan Merkow; Russel Langan; Vinod Balachandran; Monica Ragucci; Gabriella Carollo; Marcello Mancini; Luca Saba; Lorenzo Mannelli
Journal:  Acad Radiol       Date:  2018-01-17       Impact factor: 3.173

10.  Role of CT and MR in detection and staging of pancreatic adenocarcinoma.

Authors:  Isaac R Francis
Journal:  Cancer Imaging       Date:  2003-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.